1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > House Dust Mite Allergy Global Clinical Trials Review, H2, 2014

House Dust Mite Allergy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “House Dust Mite Allergy Global Clinical Trials Review, H2, 2014" provides data on the House Dust Mite Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on House Dust Mite Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating House Dust Mite Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

House Dust Mite Allergy Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
House Dust Mite Allergy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of House Dust Mite Allergy to Immunology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of House Dust Mite Allergy to Immunology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of House Dust Mite Allergy 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in House Dust Mite Allergy Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
ALK-Abello A/S 31
Clinical Trial Overview of ALK-Abello A/S 31
Stallergenes S.A. 32
Clinical Trial Overview of Stallergenes S.A. 32
Merck and Co., Inc. 33
Clinical Trial Overview of Merck and Co., Inc. 33
Circassia Holdings Ltd. 34
Clinical Trial Overview of Circassia Holdings Ltd. 34
Laboratorios LETI S.L. 35
Clinical Trial Overview of Laboratorios LETI S.L. 35
Japan Tobacco Inc. 36
Clinical Trial Overview of Japan Tobacco Inc. 36
Cytos Biotechnology AG (Inactive) 37
Clinical Trial Overview of Cytos Biotechnology AG (Inactive) 37
Merck KGaA 38
Clinical Trial Overview of Merck KGaA 38
Lofarma S.p.A. 39
Clinical Trial Overview of Lofarma S.p.A. 39
Anergis SA 40
Clinical Trial Overview of Anergis SA 40
Clinical Trial Overview of Top Institutes / Government 41
Medical University of Lodz 41
Clinical Trial Overview of Medical University of Lodz 41
Johann Wolfgang Goethe University Hospitals 42
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 42
Universitaire Ziekenhuizen Leuven 43
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven 43
Academic Medical Center 44
Clinical Trial Overview of Academic Medical Center 44
Ankara University 45
Clinical Trial Overview of Ankara University 45
Aalborg University 46
Clinical Trial Overview of Aalborg University 46
University of South Florida 47
Clinical Trial Overview of University of South Florida 47
Medical University of Silesia 48
Clinical Trial Overview of Medical University of Silesia 48
Bayside Health 49
Clinical Trial Overview of Bayside Health 49
Medical University of Vienna 50
Clinical Trial Overview of Medical University of Vienna 50
Five Key Clinical Profiles 51
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 73

List of Tables

House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Region, 2014* 7
House Dust Mite Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
House Dust Mite Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
House Dust Mite Allergy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
House Dust Mite Allergy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
House Dust Mite Allergy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of House Dust Mite Allergy to Immunology Clinical Trials, G7 Countries (%), 2014* 14
House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of House Dust Mite Allergy to Immunology Clinical Trials, E7 Countries (%), 2014* 17
House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Phase, 2014* 20
House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
House Dust Mite Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
House Dust Mite Allergy Therapeutics, Global, Suspended Clinical Trials, 2014* 24
House Dust Mite Allergy Therapeutics, Global, Terminated Clinical Trials, 2014* 25
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
House Dust Mite Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALK-Abello A/S, 2014* 31
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stallergenes S.A., 2014* 32
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 33
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Circassia Holdings Ltd., 2014* 34
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios LETI S.L., 2014* 35
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Tobacco Inc., 2014* 36
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytos Biotechnology AG (Inactive), 2014* 37
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2014* 38
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Lofarma S.p.A., 2014* 39
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Anergis SA, 2014* 40
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Lodz, 2014* 41
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 42
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014* 43
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 44
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ankara University, 2014* 45
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aalborg University, 2014* 46
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014* 47
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2014* 48
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2014* 49
House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 50

List of Figures

House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
House Dust Mite Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
House Dust Mite Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
House Dust Mite Allergy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
House Dust Mite Allergy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of House Dust Mite Allergy to Immunology Clinical Trials, G7 Countries (%), 2014* 14
House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of House Dust Mite Allergy to Immunology Clinical Trials, E7 Countries (%), 2014* 17
House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
House Dust Mite Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
House Dust Mite Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
House Dust Mite Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.